CLASS II Device recall · Reported 20 Feb 2013 · FDA Enforcement Report

Xpect Clostridium difficile Toxin A/B, IVD recalled by Remel

Remel is recalling Remel Xpect Clostridium difficile Toxin A/B, IVD, 40 clostridium difficile toxin A/B tests, distributed nationwide in the US. The recall was initiated on 20 Aug 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 141764
Quantity recalled50 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0807-2013
FDA event ID
63558
Recalling firm
Remel, Lenexa, KS
Classification
Class II
Status
Terminated
Recall initiated
20 Aug 2012
FDA classified
12 Feb 2013
Reported
20 Feb 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Botulism

Timeline

20 Aug 2012Recall initiated by company
12 Feb 2013Classified by FDA+176 days
20 Feb 2013Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The firm is recalling the products due to a potential for false negative test results.

Product as listed by the FDA

Remel Xpect Clostridium difficile Toxin A/B, IVD, 40 clostridium difficile toxin A/B tests, REF 24640. Product Usage: The test kit is a rapid in vitro immunochromatographic test for the direct, qualitative detection of Clostridium difficile Toxin A and/or B in human fecal specimens. The test is intended for use as an aid in diagnosis of Clostridium difficile-associated disease.

Where it was distributed

Worldwide Distribution - USA Nationwide and the countries Canada and the United Kingdom

Nationwide

Questions about this recall

Is Xpect Clostridium difficile Toxin A/B, IVD, 40 clostridium difficile toxin A/B tests recalled?

Yes. Remel recalled Xpect Clostridium difficile Toxin A/B, IVD, 40 clostridium difficile toxin A/B tests on 20 Aug 2012. The recall is Class II and its status is Terminated. Recall number Z-0807-2013.

Why was it recalled?

The firm is recalling the products due to a potential for false negative test results.

Which lots are affected?

Lot 141764

Where was it sold?

Worldwide Distribution - USA Nationwide and the countries Canada and the United Kingdom

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Remel

All 86
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIGC Agar Base R04030 recalled by RemelRemelOtherNationwide
DeviceCLASS IIYeastone Broth, 10/BOX YY3462 recalled by RemelRemelMoldNationwide
DeviceCLASS IICampy CVA Medium, R01272 recalled by RemelRemelOtherNationwide
DeviceCLASS IICamhb W/lhb, Manual, 10/box Ycp112-10 Brucella Broth, 10/box Yt3450 recalledRemelOtherNationwide
DeviceCLASS IIBlood/EMB, Levine, Product Number R02041 recalled by RemelRemelListeriaNationwide

Other Test Kits & Diagnostics recalls

All 2,656